Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men

Background: Not only low-density lipoprotein (LDL) cholesterol but also non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coron...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in cardiovascular medicine 2021-11, Vol.8, p.756057-756057, Article 756057
Hauptverfasser: Yoshida, Hiroshi, Ito, Kumie, Manita, Daisuke, Sato, Ryo, Hiraishi, Chika, Matsui, Sadako, Hirowatari, Yuji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 756057
container_issue
container_start_page 756057
container_title Frontiers in cardiovascular medicine
container_volume 8
creator Yoshida, Hiroshi
Ito, Kumie
Manita, Daisuke
Sato, Ryo
Hiraishi, Chika
Matsui, Sadako
Hirowatari, Yuji
description Background: Not only low-density lipoprotein (LDL) cholesterol but also non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coronary heart disease (CHD). We reported the relevance of IDL-C to Framingham risk score (F-score), but the present study addressed the relevance of IDL-C to Suita score (S-score), a risk score for coronary heart disease (CHD) developed for the Japanese individuals in addition to F-score.Methods: The cholesterol levels of lipoproteins, including triglyceride (TG)-rich lipoproteins (IDL and VLDL), were measured by an anion exchange high-performance liquid chromatography (AEX-HPLC). This study enrolled 476 men, aged mean 51 years and free of CHD and stroke.Results: Non-HDL-C, IDL-C, and VLDL-C significantly correlated with F-score and S-score. In the multiple stepwise regression analysis, IDL-C as well as body mass index (BMI) significantly correlated with both F-score and S-score in both the total subjects and the subjects without drug therapy. The multivariate logistic analysis with the model composed of BMI and IDL-C as the predictor variables demonstrated that 1 SD increase in IDL-C was an independent predictor for 10-year CHD risk >10% of F-score (OR 1.534, 95% CI 1.266-1.859, p < 0001) and that of S-score (OR 1.372, 95% CI 1.130-1.667, p = 0.0014) in the total subjects. Even in the subjects without the drug therapy, the increased IDL-C, as well as BMI, were significant predictors for 10-year CHD risk >10% of S-score as well as F-score.Conclusion: These results suggest the significant relevance of the increased IDL-C for CHD risk scores in middle-aged men free of CHD and stroke. Further investigations are needed in women and elderly subjects.
doi_str_mv 10.3389/fcvm.2021.756057
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_3389_fcvm_2021_756057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_a567fe1be9734ca7a0c06e0c5deca449</doaj_id><sourcerecordid>2623077571</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-74af452a7e5113cb35b733aa4e7691b86e6d9f99be90e734686a9a1d4e87f10d3</originalsourceid><addsrcrecordid>eNqNkktr3DAUhU1paUKafZdaFoonkvWyN4XgSZuBCS19QHfiWr6eKPVIU8mTkh_S_xs5E0Kz60JISOd8utx7iuItowvO6-ZssLfbRUUrttBSUalfFMdV1eiSSvnz5T_no-I0pRtKKZOilqp-XRxxUdeM0_q4-NuOzjsLI_nmNt4N-egtkjCQlZ8wbrF3MGG5RJ_cdEfWbhd2MUzoPGmvw4gpi8JIljiLnYfJBU8gESBfYvbaKUQy5NWGGDzEO3KJECeydAkhIfnq0i-SWVeu70cszzfYkyv0b4pXA4wJTx_3k-LHx4vv7WW5_vxp1Z6vSyt4M5VawCBkBRolY9x2XHaacwCBWjWsqxWqvhmapsOGouZC1QoaYL3AWg-M9vykWB24fYAbs4tum0s0AZx5uAhxY3K1zo5oQCo9IMuoDLKggVqqkFrZowUhmsz6cGDt9l1um0U_RRifQZ-_eHdtNuHW1EpI2cyAd4-AGH7vc2fN1iWL4wgewz6ZSlWcai01y1J6kNoYUoo4PH3DqJnDYeZwmDkc5hCObKkPlj_YhSFZh3nOT7acDi04Z4rROSitmx4m2Ya9n7L1_f9b-T2CktBS</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2623077571</pqid></control><display><type>article</type><title>Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Yoshida, Hiroshi ; Ito, Kumie ; Manita, Daisuke ; Sato, Ryo ; Hiraishi, Chika ; Matsui, Sadako ; Hirowatari, Yuji</creator><creatorcontrib>Yoshida, Hiroshi ; Ito, Kumie ; Manita, Daisuke ; Sato, Ryo ; Hiraishi, Chika ; Matsui, Sadako ; Hirowatari, Yuji</creatorcontrib><description>Background: Not only low-density lipoprotein (LDL) cholesterol but also non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coronary heart disease (CHD). We reported the relevance of IDL-C to Framingham risk score (F-score), but the present study addressed the relevance of IDL-C to Suita score (S-score), a risk score for coronary heart disease (CHD) developed for the Japanese individuals in addition to F-score.Methods: The cholesterol levels of lipoproteins, including triglyceride (TG)-rich lipoproteins (IDL and VLDL), were measured by an anion exchange high-performance liquid chromatography (AEX-HPLC). This study enrolled 476 men, aged mean 51 years and free of CHD and stroke.Results: Non-HDL-C, IDL-C, and VLDL-C significantly correlated with F-score and S-score. In the multiple stepwise regression analysis, IDL-C as well as body mass index (BMI) significantly correlated with both F-score and S-score in both the total subjects and the subjects without drug therapy. The multivariate logistic analysis with the model composed of BMI and IDL-C as the predictor variables demonstrated that 1 SD increase in IDL-C was an independent predictor for 10-year CHD risk &gt;10% of F-score (OR 1.534, 95% CI 1.266-1.859, p &lt; 0001) and that of S-score (OR 1.372, 95% CI 1.130-1.667, p = 0.0014) in the total subjects. Even in the subjects without the drug therapy, the increased IDL-C, as well as BMI, were significant predictors for 10-year CHD risk &gt;10% of S-score as well as F-score.Conclusion: These results suggest the significant relevance of the increased IDL-C for CHD risk scores in middle-aged men free of CHD and stroke. Further investigations are needed in women and elderly subjects.</description><identifier>ISSN: 2297-055X</identifier><identifier>EISSN: 2297-055X</identifier><identifier>DOI: 10.3389/fcvm.2021.756057</identifier><identifier>PMID: 34881308</identifier><language>eng</language><publisher>LAUSANNE: Frontiers Media Sa</publisher><subject>Cardiac &amp; Cardiovascular Systems ; Cardiovascular Medicine ; Cardiovascular System &amp; Cardiology ; Framingham risk score ; IDL-cholesterol ; Life Sciences &amp; Biomedicine ; Non-HDL cholesterol ; Science &amp; Technology ; Suita score ; VLDL-cholesterol</subject><ispartof>Frontiers in cardiovascular medicine, 2021-11, Vol.8, p.756057-756057, Article 756057</ispartof><rights>Copyright © 2021 Yoshida, Ito, Manita, Sato, Hiraishi, Matsui and Hirowatari. 2021 Yoshida, Ito, Manita, Sato, Hiraishi, Matsui and Hirowatari</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000743316100001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c439t-74af452a7e5113cb35b733aa4e7691b86e6d9f99be90e734686a9a1d4e87f10d3</citedby><cites>FETCH-LOGICAL-c439t-74af452a7e5113cb35b733aa4e7691b86e6d9f99be90e734686a9a1d4e87f10d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645599/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645599/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27928,27929,53795,53797</link.rule.ids></links><search><creatorcontrib>Yoshida, Hiroshi</creatorcontrib><creatorcontrib>Ito, Kumie</creatorcontrib><creatorcontrib>Manita, Daisuke</creatorcontrib><creatorcontrib>Sato, Ryo</creatorcontrib><creatorcontrib>Hiraishi, Chika</creatorcontrib><creatorcontrib>Matsui, Sadako</creatorcontrib><creatorcontrib>Hirowatari, Yuji</creatorcontrib><title>Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men</title><title>Frontiers in cardiovascular medicine</title><addtitle>FRONT CARDIOVASC MED</addtitle><description>Background: Not only low-density lipoprotein (LDL) cholesterol but also non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coronary heart disease (CHD). We reported the relevance of IDL-C to Framingham risk score (F-score), but the present study addressed the relevance of IDL-C to Suita score (S-score), a risk score for coronary heart disease (CHD) developed for the Japanese individuals in addition to F-score.Methods: The cholesterol levels of lipoproteins, including triglyceride (TG)-rich lipoproteins (IDL and VLDL), were measured by an anion exchange high-performance liquid chromatography (AEX-HPLC). This study enrolled 476 men, aged mean 51 years and free of CHD and stroke.Results: Non-HDL-C, IDL-C, and VLDL-C significantly correlated with F-score and S-score. In the multiple stepwise regression analysis, IDL-C as well as body mass index (BMI) significantly correlated with both F-score and S-score in both the total subjects and the subjects without drug therapy. The multivariate logistic analysis with the model composed of BMI and IDL-C as the predictor variables demonstrated that 1 SD increase in IDL-C was an independent predictor for 10-year CHD risk &gt;10% of F-score (OR 1.534, 95% CI 1.266-1.859, p &lt; 0001) and that of S-score (OR 1.372, 95% CI 1.130-1.667, p = 0.0014) in the total subjects. Even in the subjects without the drug therapy, the increased IDL-C, as well as BMI, were significant predictors for 10-year CHD risk &gt;10% of S-score as well as F-score.Conclusion: These results suggest the significant relevance of the increased IDL-C for CHD risk scores in middle-aged men free of CHD and stroke. Further investigations are needed in women and elderly subjects.</description><subject>Cardiac &amp; Cardiovascular Systems</subject><subject>Cardiovascular Medicine</subject><subject>Cardiovascular System &amp; Cardiology</subject><subject>Framingham risk score</subject><subject>IDL-cholesterol</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Non-HDL cholesterol</subject><subject>Science &amp; Technology</subject><subject>Suita score</subject><subject>VLDL-cholesterol</subject><issn>2297-055X</issn><issn>2297-055X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>DOA</sourceid><recordid>eNqNkktr3DAUhU1paUKafZdaFoonkvWyN4XgSZuBCS19QHfiWr6eKPVIU8mTkh_S_xs5E0Kz60JISOd8utx7iuItowvO6-ZssLfbRUUrttBSUalfFMdV1eiSSvnz5T_no-I0pRtKKZOilqp-XRxxUdeM0_q4-NuOzjsLI_nmNt4N-egtkjCQlZ8wbrF3MGG5RJ_cdEfWbhd2MUzoPGmvw4gpi8JIljiLnYfJBU8gESBfYvbaKUQy5NWGGDzEO3KJECeydAkhIfnq0i-SWVeu70cszzfYkyv0b4pXA4wJTx_3k-LHx4vv7WW5_vxp1Z6vSyt4M5VawCBkBRolY9x2XHaacwCBWjWsqxWqvhmapsOGouZC1QoaYL3AWg-M9vykWB24fYAbs4tum0s0AZx5uAhxY3K1zo5oQCo9IMuoDLKggVqqkFrZowUhmsz6cGDt9l1um0U_RRifQZ-_eHdtNuHW1EpI2cyAd4-AGH7vc2fN1iWL4wgewz6ZSlWcai01y1J6kNoYUoo4PH3DqJnDYeZwmDkc5hCObKkPlj_YhSFZh3nOT7acDi04Z4rROSitmx4m2Ya9n7L1_f9b-T2CktBS</recordid><startdate>20211122</startdate><enddate>20211122</enddate><creator>Yoshida, Hiroshi</creator><creator>Ito, Kumie</creator><creator>Manita, Daisuke</creator><creator>Sato, Ryo</creator><creator>Hiraishi, Chika</creator><creator>Matsui, Sadako</creator><creator>Hirowatari, Yuji</creator><general>Frontiers Media Sa</general><general>Frontiers Media S.A</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20211122</creationdate><title>Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men</title><author>Yoshida, Hiroshi ; Ito, Kumie ; Manita, Daisuke ; Sato, Ryo ; Hiraishi, Chika ; Matsui, Sadako ; Hirowatari, Yuji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-74af452a7e5113cb35b733aa4e7691b86e6d9f99be90e734686a9a1d4e87f10d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiac &amp; Cardiovascular Systems</topic><topic>Cardiovascular Medicine</topic><topic>Cardiovascular System &amp; Cardiology</topic><topic>Framingham risk score</topic><topic>IDL-cholesterol</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Non-HDL cholesterol</topic><topic>Science &amp; Technology</topic><topic>Suita score</topic><topic>VLDL-cholesterol</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshida, Hiroshi</creatorcontrib><creatorcontrib>Ito, Kumie</creatorcontrib><creatorcontrib>Manita, Daisuke</creatorcontrib><creatorcontrib>Sato, Ryo</creatorcontrib><creatorcontrib>Hiraishi, Chika</creatorcontrib><creatorcontrib>Matsui, Sadako</creatorcontrib><creatorcontrib>Hirowatari, Yuji</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshida, Hiroshi</au><au>Ito, Kumie</au><au>Manita, Daisuke</au><au>Sato, Ryo</au><au>Hiraishi, Chika</au><au>Matsui, Sadako</au><au>Hirowatari, Yuji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men</atitle><jtitle>Frontiers in cardiovascular medicine</jtitle><stitle>FRONT CARDIOVASC MED</stitle><date>2021-11-22</date><risdate>2021</risdate><volume>8</volume><spage>756057</spage><epage>756057</epage><pages>756057-756057</pages><artnum>756057</artnum><issn>2297-055X</issn><eissn>2297-055X</eissn><abstract>Background: Not only low-density lipoprotein (LDL) cholesterol but also non-high-density lipoprotein cholesterol (non-HDL-C), very low-density lipoprotein (VLDL) cholesterol (VLDL-C), and intermediate-density lipoprotein (IDL) cholesterol (IDL-C) are reported to be significant risk markers for coronary heart disease (CHD). We reported the relevance of IDL-C to Framingham risk score (F-score), but the present study addressed the relevance of IDL-C to Suita score (S-score), a risk score for coronary heart disease (CHD) developed for the Japanese individuals in addition to F-score.Methods: The cholesterol levels of lipoproteins, including triglyceride (TG)-rich lipoproteins (IDL and VLDL), were measured by an anion exchange high-performance liquid chromatography (AEX-HPLC). This study enrolled 476 men, aged mean 51 years and free of CHD and stroke.Results: Non-HDL-C, IDL-C, and VLDL-C significantly correlated with F-score and S-score. In the multiple stepwise regression analysis, IDL-C as well as body mass index (BMI) significantly correlated with both F-score and S-score in both the total subjects and the subjects without drug therapy. The multivariate logistic analysis with the model composed of BMI and IDL-C as the predictor variables demonstrated that 1 SD increase in IDL-C was an independent predictor for 10-year CHD risk &gt;10% of F-score (OR 1.534, 95% CI 1.266-1.859, p &lt; 0001) and that of S-score (OR 1.372, 95% CI 1.130-1.667, p = 0.0014) in the total subjects. Even in the subjects without the drug therapy, the increased IDL-C, as well as BMI, were significant predictors for 10-year CHD risk &gt;10% of S-score as well as F-score.Conclusion: These results suggest the significant relevance of the increased IDL-C for CHD risk scores in middle-aged men free of CHD and stroke. Further investigations are needed in women and elderly subjects.</abstract><cop>LAUSANNE</cop><pub>Frontiers Media Sa</pub><pmid>34881308</pmid><doi>10.3389/fcvm.2021.756057</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2297-055X
ispartof Frontiers in cardiovascular medicine, 2021-11, Vol.8, p.756057-756057, Article 756057
issn 2297-055X
2297-055X
language eng
recordid cdi_crossref_primary_10_3389_fcvm_2021_756057
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Cardiac & Cardiovascular Systems
Cardiovascular Medicine
Cardiovascular System & Cardiology
Framingham risk score
IDL-cholesterol
Life Sciences & Biomedicine
Non-HDL cholesterol
Science & Technology
Suita score
VLDL-cholesterol
title Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T01%3A50%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Significance%20of%20Intermediate-Density%20Lipoprotein%20Cholesterol%20Determination%20as%20a%20Predictor%20for%20Coronary%20Heart%20Disease%20Risk%20in%20Middle-Aged%20Men&rft.jtitle=Frontiers%20in%20cardiovascular%20medicine&rft.au=Yoshida,%20Hiroshi&rft.date=2021-11-22&rft.volume=8&rft.spage=756057&rft.epage=756057&rft.pages=756057-756057&rft.artnum=756057&rft.issn=2297-055X&rft.eissn=2297-055X&rft_id=info:doi/10.3389/fcvm.2021.756057&rft_dat=%3Cproquest_cross%3E2623077571%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2623077571&rft_id=info:pmid/34881308&rft_doaj_id=oai_doaj_org_article_a567fe1be9734ca7a0c06e0c5deca449&rfr_iscdi=true